CNTX Next Earnings Date Notes

— Context Therapeutics (ticker: CNTX) is a clinical-stage biopharmaceutical company focused on developing novel therapies for solid tumors, with an emphasis on female cancers such as breast, ovarian, & endometrial cancer. Their lead program, onapristone extended release (ONA-XR), is an oral antiprogestin designed to block progesterone receptors in cancer cells, aiming to overcome hormonal resistance and improve patient outcomes. For investors tracking Context Therapeutics, key metrics to monitor include the pace & results of clinical trial enrollments, readouts on safety & efficacy from ongoing Phase 2 studies, and updates on regulatory strategy or potential partnerships. Since the company is pre-revenue, R&D expenses, cash burn rate, & projected runway are critical to gauge the company's ability to fund its research agenda until milestones or inflection points are reached. Listen for management discussion regarding clinical milestones, collaborations, or potential fast-track designations, as well as plans to advance their drug pipeline. These indicators will give investors insight into both near-term execution & long-term value creation as Context advances its unique targeted therapies for underserved cancers. The next projected earnings date for CNTX is 8/5/2026 after close (stay tuned for a confirmed earnings date once announced).

CNTX Next Earnings Date FAQ

On this page we presented the CNTX Next Earnings Date information for Context Therapeutics along with recent past earnings dates. For Q1 of 2026, CNTX reported earnings of -0.090/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, CNTX reported earnings of -0.140/share, with the earnings report taking place on 3/23/2026. For Q3 of 2025, CNTX reported earnings of -0.100/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, CNTX reported earnings of -0.090/share, with the earnings report taking place on 8/6/2025. For Q1 of 2025, CNTX reported earnings of -0.050/share, with the earnings report taking place on 5/7/2025. Based on these past earnings dates, the projected next earnings date for CNTX is 8/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Context Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Context Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Context Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next CNTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up CNTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the CNTX next earnings date.